top of page
Executive Spotlights

Procyrion successfully secures $57.7M in series E funding

Houston, February 5, 2024 (PRNewswire) -- Procyrion™, Inc., focused on enhancing patient outcomes in cardiac and renal care, has announced the successful closure of a $57.7 million series E funding round.  These funds are earmarked to further advance the ongoing DRAIN-HF pivotal IDE trial, regarding the Aortix™ percutaneous mechanical circulatory support (pMCS) device in addressing acute decompensated heart failure (ADHF) among patients who continue to experience congestion despite standard medical interventions (known as cardiorenal syndrome or CRS).


Read full article here.

Recent Posts

See All

Radiant Vision Systems Appoints new CEO

Redmond, WA, July 1, 2024 (Radiant) -- Radiant Vision Systems has appointed Stone Jiang as their new CEO, succeeding Doug Kreysar who is retiring. Jiang, previously the Executive Vice President and

Orion and Merck Secure $1.63B Agreement

Rahway, NJ, July 1, 2024 (Business Wire) -- Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, and Orion Corporation ("Orion") have agreed to convert their co-development and co-commercial

コメント


Life Science Headlines
bottom of page